Amadeus Capital Partners and Abcam founder Jonathan Milner have teamed up to invest in Healx, a British startup working with patient advocacy groups to repurpose drugs for rare diseases. Healx will ...
WALTHAM, Mass.--(BUSINESS WIRE)--BostonGene, a leading provider of AI-driven, molecular and immune profiling solutions, today announced that it has been named a leading innovator in AI drug ...
New Technologies Will Enable Every Cure to Bolster its Computational Drug Development, Drug Repurposing, and Clinical Trial Simulation Efforts – Uncovering More Approved Drugs to Treat Patients ...
Old drugs, new ideas. That’s one of the core drivers of using artificial intelligence (AI) for drug development. Researchers using complex AI-fueled methods are now taking aim at what has become a ...
London, July 1, 2024: The Drug Repurposing & Repositioning Inventions Boardroom provided a deep dive on this important topic with industry experts from NLO, 3D-PharmXchange, and the Repo4EU consortium ...
As of January 27, the global tally of SARS-CoV-2 infections has surpassed 100 million, with fatalities reaching 2 million. Remarkably, approximately 30 million confirmed cases remain untreated with ...
Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...
Scientists have identified a potential new treatment strategy for Alzheimer’s disease using a combination of two existing ...
We are living in an era where biology has become synonymous with big data due to the ever-increasing amount of data being generated by technologies such as next-generation sequencing. Bioinformatics ...
Researchers are studying whether existing, safe medicines could be adapted to treat dementia. This is known as drug repurposing, and it offers fresh hope for finding effective dementia treatments ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback